Scholars@Duke publication: TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS

TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS

Publication , Conference

Crawford, J; Guntupalli, KK; Dean, NC; Morris, PE; Malik, RK; Schaunberg, JP

Published in: JOURNAL OF THORACIC ONCOLOGY

June 1, 2011

JOURNAL OF THORACIC ONCOLOGY

1556-0864

June 1, 2011

S1487 / S1487

LIPPINCOTT WILLIAMS & WILKINS

APA

Chicago

ICMJE

MLA

NLM

Crawford, J., Guntupalli, K. K., Dean, N. C., Morris, P. E., Malik, R. K., & Schaunberg, J. P. (2011). TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS. In JOURNAL OF THORACIC ONCOLOGY (Vol. 6, pp. S1487–S1487). LIPPINCOTT WILLIAMS & WILKINS.

Crawford, Jeffrey, Kalpalatha K. Guntupalli, Nathan C. Dean, Peter E. Morris, Rajesh K. Malik, and John P. Schaunberg. “TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS.” In JOURNAL OF THORACIC ONCOLOGY, 6:S1487–S1487. LIPPINCOTT WILLIAMS & WILKINS, 2011.

Crawford J, Guntupalli KK, Dean NC, Morris PE, Malik RK, Schaunberg JP. TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS. In: JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2011. p. S1487–S1487.

Crawford, Jeffrey, et al. “TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS.” JOURNAL OF THORACIC ONCOLOGY, vol. 6, no. 6, LIPPINCOTT WILLIAMS & WILKINS, 2011, pp. S1487–S1487.

Crawford J, Guntupalli KK, Dean NC, Morris PE, Malik RK, Schaunberg JP. TALACTOFERRIN ALFA (TLF) REDUCES MORTALITY ACROSS A BROAD RANGE OF PATIENTS WITH SEVERE SEPSIS. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2011. p. S1487–S1487.

JOURNAL OF THORACIC ONCOLOGY

1556-0864

June 1, 2011

S1487 / S1487

LIPPINCOTT WILLIAMS & WILKINS